Medicamen Biotech Limited (NSE:MEDICAMEQ)
India · Delayed Price · Currency is INR 281.10
+23.00 (8.91%)
May 5, 2026, 3:30 PM IST
Medicamen Biotech Market Cap
Medicamen Biotech has a market cap or net worth of 3.56 billion as of May 5, 2026. Its market cap has decreased by -43.56% in one year.
Market Cap
3.56B
Enterprise Value
3.51B
Revenue
1.72B
Ranking
n/a
PE Ratio
45.86
Stock Price
281.10
Market Cap Chart
Since January 12, 2005, Medicamen Biotech's market cap has increased from 108.49M to 3.56B, an increase of 3,182.70%. That is a compound annual growth rate of 17.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 3.56B | -22.85% |
| Dec 31, 2025 | 4.62B | -28.94% |
| Dec 31, 2024 | 6.50B | -14.77% |
| Dec 29, 2023 | 7.62B | -27.09% |
| Dec 30, 2022 | 10.45B | -3.50% |
| Dec 31, 2021 | 10.83B | 86.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 13.43B |
| Ind-Swift Laboratories | 11.93B |
| Sigachi Industries | 7.72B |
| Valiant Laboratories | 4.23B |
| Bafna Pharmaceuticals | 3.17B |
| Nectar Lifesciences | 2.38B |
| Brooks Laboratories | 1.65B |
| Balaxi Pharmaceuticals | 1.47B |